Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Persu

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
Journal of Hypertension|February 4, 2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)Pantelis A Sarafidis, Alexandre Persu, Rajiv Agarwal, et al.
JAMA Cardiology|September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical TrialJean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)Pantelis A Sarafidis, Alexandre Persu, Rajiv Agarwal, et al.
European Radiology|March 9, 2017
Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiographyMargreet F Sanders, Pieter Jan van Doormaal, Martine M A Beeftink, et al.
Journal of Hypertension|October 19, 2017
Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysisAlexandre Persu, Daniel Gordin, Lotte Jacobs, et al.
Journal of Hypertension|January 9, 2020
Dissecting visceral fibromuscular dysplasia reveals a new vascular phenotype of the disease: a report from the ARCADIA-POL studyEwa Warchoł-Celińska, Krzysztof Pieluszczak, Marco Pappaccogli, et al.
JAMA Cardiology|November 24, 2021
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery DissectionAlexandre Persu, Marilucy Lopez-Sublet, Abtehale Al-Hussaini, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and ParagangliomasLucie Evenepoel, Francien H van Nederveen, Lindsey Oudijk, et al.
Hypertension (Dallas, Tex. : 1979)|March 26, 2014
Eligibility for renal denervation: experience at 11 European expert centersAlexandre Persu, Yu Jin, Marie Baelen, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
Journal of Hypertension|February 4, 2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)Pantelis A Sarafidis, Alexandre Persu, Rajiv Agarwal, et al.
JAMA Cardiology|September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical TrialJean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)Pantelis A Sarafidis, Alexandre Persu, Rajiv Agarwal, et al.
European Radiology|March 9, 2017
Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiographyMargreet F Sanders, Pieter Jan van Doormaal, Martine M A Beeftink, et al.
Journal of Hypertension|October 19, 2017
Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysisAlexandre Persu, Daniel Gordin, Lotte Jacobs, et al.
Journal of Hypertension|January 9, 2020
Dissecting visceral fibromuscular dysplasia reveals a new vascular phenotype of the disease: a report from the ARCADIA-POL studyEwa Warchoł-Celińska, Krzysztof Pieluszczak, Marco Pappaccogli, et al.
JAMA Cardiology|November 24, 2021
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery DissectionAlexandre Persu, Marilucy Lopez-Sublet, Abtehale Al-Hussaini, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and ParagangliomasLucie Evenepoel, Francien H van Nederveen, Lindsey Oudijk, et al.
Hypertension (Dallas, Tex. : 1979)|March 26, 2014
Eligibility for renal denervation: experience at 11 European expert centersAlexandre Persu, Yu Jin, Marie Baelen, et al.
Pageof 15